Osaka, Japan

Wataru Fujii

This inventor holds 1 USPTO granted patent. Top assignee: Suntory Limited. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wataru Fujii. Retrieved from https://idiyas.com/inventor/wataru-fujii-gfmab7p0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wataru Fujii: Innovator in Hyaluronidase Inhibition

Introduction

Wataru Fujii is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals and cosmetics through his innovative research. His work focuses on the development of a hyaluronidase inhibitor that has promising applications in various industries.

Latest Patents

Wataru Fujii holds a patent for a "Hyaluronidase inhibitor containing GOD-type ellagitannin as an active ingredient." This invention is particularly noteworthy as it allows for the inhibition of hyaluronidase, an enzyme that hydrolyzes hyaluronic acid, without causing any toxicity to humans. The formulation is designed to be free from irritation or adverse effects on the skin, making it a valuable addition to both pharmaceutical and cosmetic products. He has 1 patent to his name.

Career Highlights

Fujii is associated with Suntory Limited, a well-respected company known for its commitment to innovation and quality. His work at Suntory has allowed him to explore the intersection of science and consumer products, leading to advancements that benefit both the industry and consumers.

Collaborations

Throughout his career, Wataru Fujii has collaborated with esteemed colleagues such as Tohru Kodama and Koichi Nakahara. These partnerships have fostered a collaborative environment that encourages the sharing of ideas and expertise, further enhancing the impact of their work.

Conclusion

Wataru Fujii's contributions to the field of hyaluronidase inhibition exemplify the importance of innovation in pharmaceuticals and cosmetics. His dedication to developing safe and effective products continues to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…